166 related articles for article (PubMed ID: 14613265)
1. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis.
Yelin E; Trupin L; Katz P; Lubeck D; Rush S; Wanke L
Arthritis Rheum; 2003 Nov; 48(11):3046-54. PubMed ID: 14613265
[TBL] [Abstract][Full Text] [Related]
2. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
Baumgartner SW; Fleischmann RM; Moreland LW; Schiff MH; Markenson J; Whitmore JB
J Rheumatol; 2004 Aug; 31(8):1532-7. PubMed ID: 15290731
[TBL] [Abstract][Full Text] [Related]
3. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
Ann Rheum Dis; 2006 Mar; 65(3):328-34. PubMed ID: 16079172
[TBL] [Abstract][Full Text] [Related]
4. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
[TBL] [Abstract][Full Text] [Related]
5. Community-based evaluation of etanercept in patients with rheumatoid arthritis.
Farahani P; Levine M; Gaebel K; Wang EC; Khalidi N
J Rheumatol; 2006 Apr; 33(4):665-70. PubMed ID: 16568506
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
Bathon JM; Fleischmann RM; Van der Heijde D; Tesser JR; Peloso PM; Chon Y; White B
J Rheumatol; 2006 Feb; 33(2):234-43. PubMed ID: 16465653
[TBL] [Abstract][Full Text] [Related]
7. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
Hone D; Cheng A; Watson C; Huang B; Bitman B; Huang XY; Gandra SR
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1564-72. PubMed ID: 23554320
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.
Buch MH; Seto Y; Bingham SJ; Bejarano V; Bryer D; White J; Emery P
Arthritis Rheum; 2005 Jan; 52(1):42-8. PubMed ID: 15641046
[TBL] [Abstract][Full Text] [Related]
9. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
Moreland LW; Weinblatt ME; Keystone EC; Kremer JM; Martin RW; Schiff MH; Whitmore JB; White BW
J Rheumatol; 2006 May; 33(5):854-61. PubMed ID: 16541481
[TBL] [Abstract][Full Text] [Related]
10. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
Farahani P; Levine M; Gaebel K; Thabane L
Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
[TBL] [Abstract][Full Text] [Related]
11. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
Keystone E; Freundlich B; Schiff M; Li J; Hooper M
J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
Johnsen AK; Schiff MH; Mease PJ; Moreland LW; Maier AL; Coblyn JS; Helfgott SM; Leff JA; Weinblatt ME
J Rheumatol; 2006 Apr; 33(4):659-64. PubMed ID: 16482646
[TBL] [Abstract][Full Text] [Related]
13. The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
Kristensen LE; Saxne T; Geborek P
Arthritis Rheum; 2006 Feb; 54(2):600-6. PubMed ID: 16447237
[TBL] [Abstract][Full Text] [Related]
14. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
15. Work disability in rheumatoid arthritis 10 years after the diagnosis.
Sokka T; Kautiainen H; Möttönen T; Hannonen P
J Rheumatol; 1999 Aug; 26(8):1681-5. PubMed ID: 10451062
[TBL] [Abstract][Full Text] [Related]
16. Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis.
Guis S; Balandraud N; Bouvenot J; Auger I; Toussirot E; Wendling D; Mattei JP; Nogueira L; Mugnier B; Legeron P; Landt O; Serre G; Roudier J; Roudier C
Arthritis Rheum; 2007 Dec; 57(8):1426-30. PubMed ID: 18050183
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
van Riel PL; Freundlich B; MacPeek D; Pedersen R; Foehl JR; Singh A;
Ann Rheum Dis; 2008 Aug; 67(8):1104-10. PubMed ID: 17666447
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].
Wallenius M; Rødevand E; Skomsvoll JF
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1664-6. PubMed ID: 15976836
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
[TBL] [Abstract][Full Text] [Related]
20. Comparison of rheumatoid arthritis care costs in patients starting therapy with leflunomide versus etanercept.
Yazdani C; McLaughlin T; Cummins G; Doyle J
Am J Manag Care; 2001 Sep; 7(13 Suppl):S419-26. PubMed ID: 11594238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
